Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. - Wikidata - awgldk - TriplyDB

Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.

Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.

http://www.wikidata.org/entity/Q33958462

about

Kawasaki Disease: A Clinician's Update Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children.Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas Evolution of laboratory values in patients with Kawasaki disease.Persistent fever in an infant: incomplete Kawasaki disease.Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease.Procalcitonin levels in patients with complete and incomplete Kawasaki disease.Kawasaki disease in infants.An update on Kawasaki disease II: clinical features, diagnosis, treatment and outcomes.Kawasaki disease: pathophysiology, clinical manifestations, and management.Incomplete Kawasaki disease induced by measles in a 6-month-old male infant.A male infant had subdural effusion and paroxysmal supraventricular tachycardia during the febrile episode of Kawasaki disease: a case report and literature review.Using the Electronic Medical Record to Correlate Kawasaki Disease Phenotypes With Clinical Outcomes.Diagnosis of incomplete Kawasaki disease.A Classification Tool for Differentiation of Kawasaki Disease from Other Febrile Illnesses.Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea.Diagnostic characteristics of supplemental laboratory criteria for incomplete Kawasaki disease in children with complete Kawasaki disease.Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.Two cases of Kawasaki disease with hidden neuroblastoma.Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines.[Kawasaki disease in children and adolescents].[Childhood vasculitis].Diagnosis of incomplete kawasaki disease in infants based on an inflammation at the bacille calmette-guérin inoculation site.Do predictors of incomplete Kawasaki disease exist for infants?Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.Incomplete Kawasaki disease in Egypt.Suppressed plasmablast responses in febrile infants, including children with Kawasaki disease.Whole blood transcriptional profiles as a prognostic tool in complete and incomplete Kawasaki Disease.Clinical implications in laboratory parameter values in acute Kawasaki disease for early diagnosis and proper treatment.Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome.

P2860

Q26998791-FF4CF958-414E-4419-9E69-661B43AACA49 Q30899913-1F3B085E-3271-4623-A928-DAADEBAC785F Q33771697-FF9FE77F-1720-43C0-993A-4C9EE7B8EBCA Q34631810-0E93CEF9-5A2B-4FF7-B307-95C14EB92BFD Q35096658-D8141550-BDC2-4923-8883-9BD08E67B8FC Q35184950-1BBF56ED-C66E-4A68-9E94-73E56EC0B425 Q35569106-7CF32E9B-9184-48E5-B2EA-12B337FA769B Q35576942-CE381856-C57E-473D-917B-341074FBE9D3 Q36602116-7DEE696D-9BFC-4DB4-823D-B696BB4779E7 Q37259079-5F1F2DEB-F935-4C5F-A57C-3960FA56AE35 Q37285703-BA3CD56D-4CD9-43FF-9E39-238FA7F382DE Q38104467-27AB2CF9-36CD-46FF-A49A-9A491481690E Q38205391-5EBA992A-D293-4D23-957D-459611A10AE4 Q38620770-FF23470E-8F63-4792-AD0B-A9C31E650329 Q38846437-619ABA47-B762-49E9-918E-4E962B02085B Q38850359-1D364829-4A6E-455F-A755-A4F949D5636A Q39632917-8D4E00B9-9DC5-4362-B507-28034C464701 Q39655163-CBCAB56C-DC1A-4965-8E55-1C6A1B11FFA6 Q40044321-8452D490-B1CE-4D3B-A27B-7DDED53C7411 Q40130689-3E86ABD2-C97F-4308-BE75-F7448908B189 Q40181195-73616F4D-271C-41AA-87A0-CCC310F1A859 Q40263949-450D9FCF-03D5-482E-A208-9231D6D6C5F0 Q40295717-AA434C77-D68C-4D92-8753-192208EDE4E2 Q40303824-68345492-D84E-464B-A9EF-6AD249C2B6E3 Q40898755-C9E94121-A382-4964-8B7E-54F07AD8AD9D Q42557070-3BB7599C-A321-4529-A190-E611D494F3E3 Q48366077-FAC24F55-6047-49A7-AD72-F03E6B04820D Q51403839-BD017123-ACD4-4044-B7DB-5A4F1B3811D0 Q51536488-1078568B-D72E-4AF0-9A33-D497B7219079 Q53699549-31FB6B03-C992-4BCF-979E-F09BD1EFCF73 Q54248487-73D65FE7-553F-4846-B885-ECEBBDF0AA54 Q55002256-87676AB9-C4FB-41A6-891D-C423F759E0AF Q55108848-C124C5E9-265C-4F80-96AB-B36F730B9AC2 Q55317014-FE1E6035-46AD-4FF6-BCC5-2A8B93808D64

P2860

Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.

http://www.wikidata.org/entity/Q33958462

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Performance of 2004 American H ...... treatment of Kawasaki disease.

@ast

Performance of 2004 American H ...... treatment of Kawasaki disease.

@en

type

label

Performance of 2004 American H ...... treatment of Kawasaki disease.

@ast

Performance of 2004 American H ...... treatment of Kawasaki disease.

@en

prefLabel

Performance of 2004 American H ...... treatment of Kawasaki disease.

@ast

Performance of 2004 American H ...... treatment of Kawasaki disease.

@en

P1433

Q33958462-08CAD85C-EEBA-4C96-8D88-673D7EC7F758

P1476

Q33958462-E781119E-20B1-4376-9C9D-6BF6F6505324

P2093

Q33958462-0DE69CB7-9C28-4824-9F1B-331B1326CC99

Q33958462-41DB91F1-F8D6-4152-ADB8-9289A89F5E17

Q33958462-4C4915F3-D58E-4223-B2AC-9F865EA602A9

Q33958462-56F6330C-34E8-41C1-92B0-C7E43B74B9BB

Q33958462-59FC823C-FC70-4813-A5B9-DFD0691B09F9

Q33958462-8898A2F7-0920-4FB9-B1A6-E38575010A72

Q33958462-CC972D83-731C-4D9C-AB86-DFEE83272AF9

Q33958462-CDA0D9D5-B51D-4498-88A2-D43ABB72489E

Q33958462-E5602381-73F1-4A2C-95BE-A13EF0979DF5

Q33958462-FB6426DC-C31C-4BF5-AD01-828A643C381D

P2860

Q33958462-00A2344F-5425-4557-90DE-5E0091D49D6F

Q33958462-0B20ADAC-CDE4-47FE-8640-A18841AE0026

Q33958462-0B994D4A-AD12-4268-A0EA-D5E9C97A534B

Q33958462-18C219BB-F92B-4916-8F08-5E60F8C4596F

Q33958462-3A694385-A8AE-431F-A796-E00478426D8A

Q33958462-559AC406-AECF-4DE4-B1FC-7E007FFF8878

Q33958462-6169463E-AD38-4743-9736-CE94112BDCBC

Q33958462-71D40198-C6A7-4837-810B-F0C8065066D2

Q33958462-71FB7584-693B-4E5C-ADBA-C4050708C3CB

Q33958462-72372874-1402-4619-9CC8-F918ECB209D7

P304

Q33958462-9F63A37E-117D-42B0-BFEC-B0AA3D028CA0

P31

Q33958462-53F5FDDF-7D71-44C7-A4B9-E9D835B21E66

P356

Q33958462-3E4A277C-27D9-46CE-8F67-5B69CA33DB41

P407

Q33958462-5A6131C6-CE7A-4FDC-9247-65B6919151D9

P433

Q33958462-66CF3B40-D404-45C6-8CE7-D2AB3758AAE2

P478

Q33958462-F6C5EEFB-9071-44D2-A5DD-D75BD17703E6

P50

Q33958462-42E1AA5F-1888-402A-99C9-549C057A1A12

Q33958462-72123B20-C5D8-4E83-9935-D7F9389E53D7

P577

Q33958462-2AC6005A-F0F6-420A-BBC4-51D4E5015253

P5875

Q33958462-7388E702-F4C7-48D4-837F-EAF0605513E9

P698

Q33958462-3C4FCBB8-C8B3-4B7F-81DA-9C0A5C3746FD

P932

Q33958462-832964E2-E359-4B23-A31E-D21A7B0A51AF

P356

P1433

P1476

Performance of 2004 American H ...... treatment of Kawasaki disease.

@en

P2093

Adam Ostrow

http://www.w3.org/2001/XMLSchema#string

Annette L Baker

http://www.w3.org/2001/XMLSchema#string

Chiara Zambetti

http://www.w3.org/2001/XMLSchema#string

David R Fulton

http://www.w3.org/2001/XMLSchema#string

Elizabeth S Yellen

http://www.w3.org/2001/XMLSchema#string

Jane C Burns

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Frazer

http://www.w3.org/2001/XMLSchema#string

Joan M Pancheri

http://www.w3.org/2001/XMLSchema#string

Masato Takahashi

http://www.w3.org/2001/XMLSchema#string

Nancy Innocentini

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis, treatment, and long-term management of Kawasaki disease

Characteristics of Kawasaki disease in infants younger than six months of age

Atypical and complicated Kawasaki disease in infants. Do we need criteria?

Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria.

Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome.

Clinical spectrum of Kawasaki disease in infants younger than 6 months of age.

Kawasaki disease in infants less than one year of age.

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group.

Intravenous gamma-globulin treatment in Kawasaki disease.

P304

e234-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2009-0606

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Jane W. Newburger

Kimberlee Gauvreau

P577

2010-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41139085

http://www.w3.org/2001/XMLSchema#string

P698

20100771

http://www.w3.org/2001/XMLSchema#string

P932

2896313

http://www.w3.org/2001/XMLSchema#string